Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Company Profile and bullboard matches:

T.XMD
Sort by: Date|Relevance

Biopharma to Accelerate Alzheimer Trial Completion

The upcoming catalysts for Axsome Therapeutics and the effects of COVID-19 on its clinical activities are discussed in an H.C. Wainwright & Co. report. In a March 20 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that Axsome Therapeutics Inc. ...
Streetwise Reports | March 26, 2020 |

Standard Lithium Closes Financing; Works Toward Completion of PFS

In this interview, the Critical Investor and the company CEO delve into the "impressive" capital raise and what it means for the junior's future. Building demonstration plant at Lanxess Project site After Standard Lithium Ltd. (SLL:TSX.V; STLHF:OTCQX)...
Streetwise Reports | March 2, 2020 |

Halliburton Shares Trade Higher on Q3 Earnings

Shares of Halliburton Co. at times traded greater than 8% higher after the firm reported improved Q3/19 earnings results versus Q2/19. This morning before the opening bell Halliburton Co. (HAL:NYSE) announced its third quarter earnings for the period ending Septemb...
Streetwise Reports | October 23, 2019 |

Advancing one of Canada’s Highest-Grade Gold Projects

Bonterra Resources Inc. ( TSX: V.BTR , OTCQB: BONXF , Forum ) is a well-financed Canadian gold exploration company, currently moving forward with deposit extension and resource expansion, in and around its new high-grade Gladiator Gold Deposit. We are located in the ...
Featured Submission | May 28, 2018 |

One of the largest precious metals developments in the Toogoddone District

Benchmark Metals (TSXV:BNCH) has a strong record of evaluating and advancing mining projects from inception to production. The mineral exploration company is keenly focused on its Lawyer’s Gold and Silver project which is 100 per cent owned by the co...
Brieanna McCutcheon | June 12, 2023 |

Buzz on the Bullboards: Tracking the Major Movers: Opportunities & Warnings

(Image via New Found Gold Corp.) Markets have been increasingly volatile in recent weeks. While these erratic swings can tend to fray the nerves of investors, the flip side of this is that gains can now be made in a matter of weeks (or even days) that would equate t...
Stockhouse Editorial | October 13, 2021 |

Texas Oil & Gas Firm Reports Positive Mid-Q3/19 Operations Update

Accomplishments and revised estimates are reviewed in a ROTH Capital Partners report. In an Aug. 22 research note, analyst John White reported changes to ROTH Capital Partners' model on Ring Energy Inc. (REI:NYSE) . ROTH lowered its target price on the company to $...
Streetwise Reports | August 28, 2019 |

Avadel Pharma Shares Up 30% Upon Acceleration of Phase 3 REST-ON Study

Avadel Pharmaceuticals' shares are trading 30% higher today on news that the FDA agreed to reduce the sample size required for its Phase 3 REST-ON study, accelerating its completion by year-end 2019. Dublin, Ireland-based Avadel Pharmaceuticals Plc (AVDL:NASDAQ) , wh...
Streetwise Reports | September 24, 2019 |

Iterum Therapeutics Shares Double After Completing Enrollment in Phase 3 Antibiotic Trial

Iterum Therapeutics shares traded more than 100% higher after the company reported that it has completed enrollment in its Phase 3 SURE 1 clinical study of oral sulopenem for treatment of uncomplicated urinary tract infections. The firm expects to receive topline data results ...
Streetwise Reports | December 30, 2019 |

Buzz on the Bullboards: Do the Dead Cats Bounce?

(Image via CGX Energy Inc.) You’ve heard that what goes up must come down, but in the stock trading world, what goes down should come up. Even a dead cat can bounce if it falls from high enough up, right? The markets coined this term believing th...
Stockhouse Editorial | May 11, 2022 |
1 2 3 4 5 6 7 8 9 10 ...